Literature DB >> 33291819

Prognostic Significance of Lymph Node Examination by the OSNA Method in Lung Cancer Patients-Comparison with the Standard Histopathological Procedure.

Josef Vodicka1, Martin Pesta2,3, Vlastimil Kulda4, Katerina Houfkova2, Bohuslava Vankova5, Jakub Sebek1, Martin Skala1, Jakub Fichtl1, Kristyna Prochazkova1, Ondrej Topolcan6.   

Abstract

The aim of the study was to compare the prognostic significance of lymph node status of patients with lung cancer analyzed by three different methods: hematoxylin and eosin (H&E), immunohistochemistry of cytokeratin 19 (IHC CK19), and One-Step Nucleic Acid Amplification (OSNA). The clinical relevance of the results was evaluated based on relation to prognosis; the disease-free interval (DFI) and overall survival (OS) were analyzed. During radical surgical treatment, a total of 1426 lymph nodes were obtained from 100 patients, creating 472 groups of nodes (4-5 groups per patient) and examined by H&E, IHC CK19 and OSNA. The median follow-up was 44 months. Concordant results on the lymph node status of the H&E, IHC CK19 and OSNA examinations were reported in 78% of patients. We recorded shorter OS in patients with positive results provided by both OSNA and H&E. The study demonstrated a higher percentage of detected micrometastases in lymph nodes by the OSNA method. However, the higher sensitivity of the OSNA, with the cut-off value 250 copies of mRNA of CK19/µL, resulted in a lower association of OSNA positivity with progress of the disease compared to H&E. Increasing the cut-off to 615 copies resulted in an increase in concordance between the OSNA and H&E, which means that the higher cut-off is more relevant in the case of lung tumors.

Entities:  

Keywords:  E; H& IHC CK19; OSNA; lung cancer; lymph nodes

Mesh:

Substances:

Year:  2020        PMID: 33291819      PMCID: PMC7762050          DOI: 10.3390/cells9122611

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  28 in total

1.  One-step nucleic acid amplification for detection of lymph node metastasis in lung cancer.

Authors:  Makio Hayama; Masayuki Chida; Yoko Karube; Motohiko Tamura; Satoru Kobayashi; Takeshi Oyaizu; Koichi Honma
Journal:  Ann Thorac Cardiovasc Surg       Date:  2013-04-20       Impact factor: 1.520

2.  The diagnostic value of one-step nucleic acid amplification (OSNA) for sentinel lymph nodes in colon cancer patients.

Authors:  F J Vogelaar; M S Reimers; R L A van der Linden; J C van der Linden; V T H B M Smit; D J Lips; C J H van de Velde; K Bosscha
Journal:  Ann Surg Oncol       Date:  2014-06-10       Impact factor: 5.344

3.  An accurate and rapid detection of lymph node metastasis in non-small cell lung cancer patients based on one-step nucleic acid amplification assay.

Authors:  Masayoshi Inoue; Kayo Hiyama; Kadzuki Nakabayashi; Eiichi Morii; Masato Minami; Noriyoshi Sawabata; Yasushi Shintani; Tomoyuki Nakagiri; Yoshiyuki Susaki; Jun Maeda; Masahiko Higashiyama; Jiro Okami; Yuichiro Yoshida; Junyi Ding; Yasuhiro Otomo; Meinoshin Okumura
Journal:  Lung Cancer       Date:  2012-09-29       Impact factor: 5.705

4.  Cytokeratin 19 expression in primary thoracic tumors and lymph node metastases.

Authors:  Kyohei Masai; Kazuo Nakagawa; Akihiko Yoshida; Hiroyuki Sakurai; Shun-ichi Watanabe; Hisao Asamura; Koji Tsuta
Journal:  Lung Cancer       Date:  2014-10-12       Impact factor: 5.705

5.  Cytokeratin 19 expression in early oral squamous cell carcinoma and their metastasis: Inadequate biomarker for one-step nucleic acid amplification implementation in sentinel lymph node biopsy procedure.

Authors:  Rob Noorlag; Robert J J van Es; Remco de Bree; Stefan M Willems
Journal:  Head Neck       Date:  2017-06-23       Impact factor: 3.147

6.  Sentinel node tumour burden quantified based on cytokeratin 19 mRNA copy number predicts non-sentinel node metastases in breast cancer: molecular whole-node analysis of all removed nodes.

Authors:  Tomo Osako; Takuji Iwase; Kiyomi Kimura; Rie Horii; Futoshi Akiyama
Journal:  Eur J Cancer       Date:  2012-12-19       Impact factor: 9.162

7.  Role of Skip Mediastinal Lymph Node Metastasis for Patients With Resectable Non-small-cell Lung Cancer: A Propensity Score Matching Analysis.

Authors:  Lin Wang; Cheng Zhan; Jie Gu; Junjie Xi; Zongwu Lin; Liang Xue; Di Ge; Qun Wang
Journal:  Clin Lung Cancer       Date:  2018-12-19       Impact factor: 4.785

8.  Molecular investigation of lymph nodes in colon cancer patients using one-step nucleic acid amplification (OSNA): a new road to better staging?

Authors:  Ulrich Güller; Andreas Zettl; Mathias Worni; Igor Langer; Daniela Cabalzar-Wondberg; Carsten T Viehl; Nicolas Demartines; Markus Zuber
Journal:  Cancer       Date:  2012-06-08       Impact factor: 6.860

9.  Incidence and possible pathogenesis of sentinel node micrometastases in ductal carcinoma in situ of the breast detected using molecular whole lymph node assay.

Authors:  T Osako; T Iwase; K Kimura; K Masumura; R Horii; F Akiyama
Journal:  Br J Cancer       Date:  2012-05-08       Impact factor: 7.640

10.  Quantitative molecular analysis of sentinel lymph node may be predictive of axillary node status in breast cancer classified by molecular subtypes.

Authors:  Simonetta Buglioni; Franco Di Filippo; Irene Terrenato; Beatrice Casini; Enzo Gallo; Ferdinando Marandino; Carlo L Maini; Rossella Pasqualoni; Claudio Botti; Simona Di Filippo; Edoardo Pescarmona; Marcella Mottolese
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.